Concinnity is developing an AI-driven RNA design platform to build gene control systems for gene and cell therapies. Our RNA-based control systems will form part of the gene therapy cassette and enable precise control of therapeutic activity. Such control systems have huge potential to enhance both patient safety and therapeutic efficacy, for example by allowing a gene therapy to dynamically adjust its activity in response to patient disease state, recognise tissue type, or by allowing clinical control of the therapy after administration.

Concinnity Genetics

Jessica Birt

This department provides strategic direction and overall governance for the organization.

Executive Leadership

This department focuses on research and development in the field of molecular biology.

Concinnity Genetics

Org chart

Teams

Executive Leadership

Molecular Biology

Offices